EP
CYCN icon

Eversept Partners’s Cyclerion Therapeutics CYCN Stock Holding History

Eversept Partners’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,598
Closed -$413K – 85
2022
Q1 		$413K Hold
18,598
– – 0.04% 82
2021
Q4 		$640K Hold
18,598
– – 0.05% 96
2021
Q3 		$1.14M Buy
+18,598
New +$1.22M 0.09% 94
2020
Q3 		– Sell
-12,383
Closed -$1.46M – 56
2020
Q2 		$1.46M Sell
12,383
-4,474
-27% -$374K 0.24% 54
2020
Q1 		$893K Buy
+16,857
New +$1.2M 0.24% 45
2019
Q3 		– Sell
-946
Closed -$217K – 61
2019
Q2 		$217K Buy
+946
New +$268K 0.06% 61

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $382M AUM 31.69% 1-Year Est. Return